Drugs for opioid dependence

Neonatal abstinence syndrome can be a problem

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e4200 (Published 19 June 2012)
Cite this as: BMJ 2012;344:e4200

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Helen Mactier, consultant neonatologist1,
  2. Laura McGlone, neonatal paediatric grid trainee1,
  3. Ruth Hamilton, consultant clinical scientist2,
  4. Jane R MacKinnon, consultant paediatric ophthalmologist3
  1. 1Princess Royal Maternity, Glasgow G31 2ER, UK
  2. 2Department of Clinical Physics and Bioengineering, University of Glasgow and the Royal Hospital for Sick Children, Glasgow, UK
  3. 3Royal Hospital for Sick Children, Glasgow, UK
  1. helen.mactier{at}ggc.scot.nhs.uk

Farrell and colleagues note that in pregnancy “methadone (substitution treatment) is safe and effective in terms of consistently better obstetric and perinatal outcomes.”1 They indicate that the only complication for the baby is a risk of neonatal abstinence syndrome and suggest that this “can be readily managed with withdrawal management and …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL